Singlera Genomics

A developer of 'liquid biopsy' analysis reagents and software, focusing on determing methylation haplotypes across many thousands of genomic locations in cell-free DNA.

Launch date

2013

Employees

11-50 people

Market cap

Enterprise valuation

San Diego California (HQ), Shanghai Shanghai (founding location)

https://singleraoncology.com/

https://twitter.com/luxuanx https://www.facebook.com/singleragenomics https://www.linkedin.com/company/singlera-genomics-incorporated

Date	Investors	Amount	Round
-	Guojing Brilliance	N/A	-
Aug 2016	Lilly Asia Ventures Green Pine Capital CD Capital	$20.0m	Series A
Mar 2018	Lilly Asia Ventures Green Pine Capital Prosperico Ventures	$60.0m	Series A
Dec 2020	CICC DT Capital Partners FTZ Fund Management Green Pine Capital Proxima Ventures Linden Asset Management Wuxi Capital Prosperico Ventures Fudan University Ningbo Research Institute Huamei Group FutureX Capital	$153m	Series B
Aug 2021	Junci Investment	N/A	Late VC
Jun 2022*	Sansure Biotech Galaxy Yuanhui Investment Forstone Capital Gandao Fund Qiandao Fund Fengshi Capital Bai Shide Shengxiang Bio	$45.0m Valuation: $764m	Series B
Jul 2024*	Yangzhou Longchuan Holding Group Guojin Group	CNY100m	Late VC
Total Funding		AUD450m

Tech stackLearn more about the technologies and tools that this company uses.

Singlera Genomics

Singlera Genomics

Related Content

Recent News about Singlera Genomics

Tech stack